Company
United StatesSightLife/CorneaGen, Bethlehem, PA – FDA Inspections
Inspection records and compliance data for SightLife/CorneaGen in Bethlehem, Pennsylvania. 4 FDA inspections on record, last inspected August 03, 2016.
Company Profile
This profile covers SightLife/CorneaGen based in Bethlehem, Pennsylvania, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 0
- NAI
- 4
- Form 483s
- 0
- Warning letters
- 0
First inspected March 26, 2009. Last inspected August 3, 2016.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 3, 2016 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 981753 |
| September 11, 2014 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 894961 |
| September 21, 2011 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 745752 |
| March 26, 2009 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 572644 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
SightLife/CorneaGen
FEI Number
3000718076
Address
2346 Jacksonville Rd, Bethlehem, Pennsylvania 18017, United States
Country
United States
ID: 893bd611-bd46-4e4d-bf08-6d9a6272be74